Toggle navigation
Home
Search
Services
Blog
Contact
About
Total Synthesis of Anticancer Agents - Agelastatin A
Brook, Christopher S.
University of Pennsylvania, Philadelphia, PA, United States
Search 24 grants from Christopher Brook
Search grants from University of Pennsylvania
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Enhancing molecular diagnosis in children with multiple congenital anomalies using clinically focused splicing prediction algorithms
Software Engineering Tools
Problem-Solving Training for Coping with Cancer
Phase Iib Randomized Controlled Study of Tissue Plasmin
Pathology in the Control of Differentiation in Cancer
Recently added grants:
Hypothalamic astrocyte-neuron relationship links overnutrition to hypertension
HIV Center for Clinical and Behavioral Studies
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)
Silvio O. Conte Center for Oxytocin and Social Cognition
HIV Center for Clinical and Behavioral Studies
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA066270-01
Application #
2109592
Study Section
Biomedical Sciences Study Section (BIOM)
Project Start
1995-06-27
Project End
Budget Start
1995-02-01
Budget End
1996-01-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Related projects
NIH 1996
F32 CA
Total Synthesis of Anticancer Agents - Agelastatin A
Brook, Christopher S. / University of Pennsylvania
NIH 1995
F32 CA
Total Synthesis of Anticancer Agents - Agelastatin A
Brook, Christopher S. / University of Pennsylvania
Comments
Be the first to comment on Christopher Brook's grant